Clinical Data

For more information regarding the clinical performance of LuViva® Advanced Cervical Scan, please click the links below:

Published Journal Papers:

Multimodal Hyperspectroscopy as a Triage Test for Cervical Neoplasia:  Pivotal Clinical Trial ResultsGynecologic Oncology, July 2013 – LuViva® Advanced Cervical Scan

Is Colposcopy and/or Biopsy Always Necessary?Hospital Healthcare Europe 2013 – LuViva® Advanced Cervical Scan

Comparison of Human Papilloma Virus Testing and Spectroscopy Combined With Cervical Cytology for the Detection of High-grade Cervical NeoplasiaJournal of Lower Genital Tract Disease, April 2007 – LuViva® Advanced Cervical Scan

Spectroscopic Imaging as a Triage Test for Cervical Disease:  A Prospective Multicenter Clinical TrialJournal of Lower Genital Tract Disease, January 2006 – LuViva® Advanced Cervical Scan

Women’s Responses to Cervical Interrogation by Fluorescent and Reflective SpectroscopyJournal of Lower Genital Tract Disease, April 2007 – LuViva® Advanced Cervical Scan

Multimodal Hyperspectral Imaging for the Noninvasive Diagnosis of Cervical NeoplasiaJournal of Lower Genital Tract Disease, October 2003 – LuViva® Advanced Cervical Scan

Oral Presentations:

NEW! International Federation of Gynecology and Obstetrics (FIGO) 2015 – Abnormal Spectroscopy Scans May Presage Persistent or Progressive Cervical Dysplasia – Leo B. Twiggs, M.D. – LuViva® Advanced Cervical Scan

Turkish Society of Gynecology Oncology Congress (TSGO) 2014 – Biophotonic Detection of Cervical Dysplasia:  The Transition from Clinical Trials to Real World Use – Leo B. Twiggs, M.D. – LuViva® Advanced Cervical Scan

European Congress of Obstetrics and Gynaecology (EBCOG) 2010 – Multimodal Spectroscopy as a Triage Test for Women at Risk for cervical neoplasia:  Results of a 1,607 subject pivotal trial–  Nahida Chakhtoura, M.D.LuViva® Advanced Cervical Scan

American Society for Colposcopy and Cervical Pathology (ASCCP) 2010 – Multimodal Spectroscopy as a Triage Test for Women at Risk for cervical neoplasia:  Results of a 1,607 subject pivotal trial – Leo B. Twiggs, M.D.LuViva® Advanced Cervical Scan

American Society for Colposcopy and Cervical Pathology (ASCCP) 2010 – Multimodal Spectroscopy as a Triage Test for Women at Risk for cervical neoplasia:  Results of follow up data– Nahida Chakhtoura, M.D.LuViva® Advanced Cervical Scan

INCOLO 2007 – Quantitative Optical Spectroscopy of the Uterine Cervix:  A cost effective way to detect and manage cervical disease – Nahida Chakhtoura, M.D.LuViva® Advanced Cervical Scan

American Society for Colposcopy and Cervical Pathology (ASCCP) 2006 – Comparison of HPV Testing and spectroscopy combined with cytology for the detection of high-grade cervical Neoplasia – Claudia Werner, M.D. LuViva® Advanced Cervical Scan

European Research Organisation on Genital Infection and Neoplasia (EUROGIN) 2003 – Multimodal spectroscopic imaging of the cervix for triaging patients to colposcopy Leo B. Twiggs, M.D.LuViva® Advanced Cervical Scan

Poster Presentations:

Society of Gynaecology and Obstetrics of Nigeria (SOGON) 2014 – Results of LuViva Test with Comparisons to Other Tests – Cytology, HPV, VIA and Histopathology – Professor Issac Adewole – LuViva® Advanced Cervical Scan

Society of Gynaecology and Obstetrics of Nigeria (SOGON) 2014 – Cervical Screening with LuViva Machine for Early Detection of Cervical Dysplasia:  Experience from Ekiti State, Nigeria – Ekiti State – LuViva® Advanced Cervical Scan

International Federation of Cervical Pathology and Colposcopy (IFCPC) 2014 – LuViva Cervical Scan as a triage test to reduce unnecessary colposcopy and biopsy – James Bentley, MBChB FRCSCLuViva® Advanced Cervical Scan

American Society for Colposcopy and Cervical Pathology (ASCCP) 2012 – Preliminary Assessment of cervical spectroscopy for primary screening of moderate and high grade cervical dysplasia – Lisa C. Flowers, M.D.LuViva® Advanced Cervical Scan

American Congress of Obstetricians and Gynecologists (ACOG) 2012 – Optimal Combination of cervical spectroscopy with cytology and HPV:  Implications for Clinic efficiency – Marc L. Winter, M.D. LuViva® Advanced Cervical Scan

International Society for Optics and Photonics, Photonics West 2011 – Identifying Constituent Spectra Sources in Multispectral Images to Quantify and Locate Cervical NeoplasiaLuViva® Advanced Cervical Scan

American Society for Colposcopy and Cervical Pathology (ASCCP) 2010 – Multimodal spectroscopy as a triage test for women at risk for cervical neoplasia:  experience with a low cost commercial prototype – Marc L. Winter, M.D.LuViva® Advanced Cervical Scan

American Society for Colposcopy and Cervical Pathology (ASCCP) 2010 – Multimodal spectroscopy as a triage test for women at risk for cervical neoplasia:  Histopathology review procedures and results – Ed J. Wilkinson, M.D.LuViva® Advanced Cervical Scan

American Society for Colposcopy and Cervical Pathology (ASCCP) 2010 – Multimodal spectroscopy as a triage test for women at risk for cervical neoplasia:  Results for Adolescent Patients – Lisa C. Flowers, M.D.LuViva® Advanced Cervical Scan

American Society for Colposcopy and Cervical Pathology (ASCCP) 2008 – Quantitative Optical spectroscopy offers a cost effective method for diagnosing cervical cancer

American Society for Colposcopy and Cervical Pathology (ASCCP) 2006 – Spectroscopic Imaging as a triage test for cervical disease:  A prospective multicenter clinical trial – Timothy DeSantis, M.D. LuViva® Advanced Cervical Scan